Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation

Fetal Diagnosis and Therapy

Volumn 29, Issue 4, 2011, Pages 301-306

  Akolekar, Ranjit ^a   Finning, Kirstin ^b   Kuppusamy, Ramesh ^a   Daniels, Geoff ^b   Nicolaides, Kypros H ^a,c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cell free fetal DNA; Fetal RHD genotyping; First trimester; Pyramid of prenatal care

Indexed keywords

CIRCULATING CELL FREE FETAL DNA; DNA; RHESUS D ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA ISOLATION; EXON; FEMALE; FETUS; GENOTYPE; GESTATION PERIOD; HUMAN; MATERNAL PLASMA; PHENOTYPE; PREDICTIVE VALUE; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ROBOTICS;

DNA; FEASIBILITY STUDIES; FEMALE; FETAL BLOOD; GENOTYPE; GESTATIONAL AGE; HUMANS; PHENOTYPE; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 79959314844     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000322959     Document Type: Article

References (28)

1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS: Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487. (Pubitemid 27343304)
2. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738. (Pubitemid 28555431)
3. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE: Detection of fetal RhD-specific sequences in maternal plasma. Lancet 1998;352:1196. (Pubitemid 28458542)
4. Finning KM, Martin PG, Soothill PW, Avent ND: Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002 42:1079-1085.
5. Tabor A, Bang J, Nørgaard-Pedersen B: Fetomaternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987;94:528-534. (Pubitemid 17077761)
6. Brambati B, Guercilena S, Bonacchi I, Oldrini A, Lanzani A, Piceni L: Feto-maternal transfusion after chorionic villus sampling: clinical implications. Hum Reprod 1986;1:37-40. (Pubitemid 16112429)
7. Geifman-Holtzman O, Grotegut CA, Gaughan JP: Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta-analysis. Am J Obstet Gynecol 2006; 195: 1163-1173. (Pubitemid 44415679)
8. Legler TJ, Muller SP, Haverkamp A, Grill S, Hahn S: Prenatal RhD testing: A review of studies published from 2006 to 2008. Transfus Med Hemother 2009;36:189-198.
9. Daniels G, Finning K, Martin P, Massey E: Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 2009;29:101-107.
10. Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M: Non-invasive antenatal RHD typing. Transfus Clin Biol 2006;13:53-57.
11. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G: Effect of high-throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-818. (Pubitemid 351548224)
12. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-346. (Pubitemid 28352196)
13. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH: Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free β-human chorionic gonadotropin, and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618-624.
14. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF: Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α. J Biol Chem 1996;271:17161-17166. (Pubitemid 26244268)
15. Zhang J, Fidler C, Murphy MF, Chamberlain PF, Sargent IL, Redman CW, Hjelm NM, Wainscoat JS, Lo YM: Determination of fetal RhD status by maternal plasma DNA analysis. Ann NY Acad Sci 2000;906:153-155. (Pubitemid 30255474)
16. Costa JM, Giovangrandi Y, Ernault P, Lohmann L, Nataf V, El Halali N, Gautier E: Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255-260. (Pubitemid 35176527)
17. Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK: Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 2003; 85: 300-306. (Pubitemid 37522604)
18. Brojer E, Zupanska B, Guz K, Orziñska A, Kaliñska A: Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 2005: 45: 1473-1480. (Pubitemid 44194651)
19. Al-Yatama MK, Mustafa AS, Al-Kandari FM, Khaja N, Zohra K, Monem RA, Abraham S: Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy. Med Princ Pract 2007;16:327-332. (Pubitemid 47294486)
20. Machado IN, Castilho L, Pellegrino J Jr, Barini R: Fetal RHD genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 2006;52:232-235. (Pubitemid 44372073)
21. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM: Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008;48:373-381.
22. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, Narter-Olaga EG, Hawthorne LM, Daniels G: The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-18. (Pubitemid 30017219)
23. Freeman K, Szczepura A, Osipenko L: Noninvasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. Eur J Obstet Gynecol Reprod Biol 2009;142:91-98.
24. Wright CF, Burton H: The use of cell-free fetal nucleic acids in maternal blood for noninvasive prenatal diagnosis. Hum Reprod Update 2009;15:139-151.
25. Page-Christiaens GC, Bossers B, van der Schoot CE, DE Haas M: Use of bi-allelic insertion/ deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experience. Ann NY Acad Sci. 2006;1075:123-129. (Pubitemid 44532774)
26. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM: Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211-2218. (Pubitemid 44924994)
27. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775. (Pubitemid 28194317)
28. Daniels G: Human Blood Groups, ed 2. Oxford, Blackwell Science, 2002.